Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jun 7, 2026

Inducible and Reversible Dominant-negative (DN) Protein Inhibition

Inducible and Reversible Dominant-negative (DN) Protein Inhibition

Published on: January 7, 2019

PTD-DRBD siRNA delivery.

Caroline Palm-Apergi¹, Akiko Eguchi, Steven F Dowdy

¹Department of Cellular and Molecular Medicine, UCSD School of Medicine, Howard Hughes Medical Institute, La Jolla, CA, USA.

Methods in Molecular Biology (Clifton, N.J.)

|November 6, 2010

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Profiling of extracellular vesicles from primary hepatocytes, organoids, and mash patients identifies cell injury-specific signatures.

Scientific reports·2026

Same author

Conjugated Bile Acids and the Liver-Muscle Axis: Authors' Reply to the Perspectives on Causal and Contextual Interpretation.

Liver international : official journal of the International Association for the Study of the Liver·2026

Same author

The Conjugated Bile Acids Profile Suggests a Novel Liver-Muscle Axis Associated With Sarcopenia in Chronic Liver Disease.

Liver international : official journal of the International Association for the Study of the Liver·2026

Same author

Plexin Domain Containing 2, a Protein Specifically Expressed and Elevated in Human Pancreatic Cancer Tissue and Serum, Influences Cell Proliferation by Correlating With Cortactin.

Cancer medicine·2025

Same author

Stimulation at the frontal cortex influences the exercise activity and skeletal muscle status in senescence-accelerating mice.

npj aging·2025

Same author

Clinical Evaluation of Oxidative Stress Markers in Patients with Long COVID During the Omicron Phase in Japan.

Antioxidants (Basel, Switzerland)·2025

This study introduces a novel protein-based delivery system for short-interfering RNA (siRNA). This method effectively overcomes cell membrane barriers, enabling efficient and non-toxic mRNA degradation for therapeutic applications.

Area of Science:

Biotechnology
Molecular Biology
Drug Delivery Systems

Background:

Cellular drug delivery faces challenges with hydrophilic molecules like siRNA crossing the plasma membrane.
Short-interfering RNA (siRNA) is a potent therapeutic agent but struggles with cellular uptake and aggregation.
Protein transduction domains (PTDs) show potential for delivering siRNA but often lead to precipitation.

Purpose of the Study:

To develop an effective and non-toxic delivery strategy for siRNA into cells.
To overcome the limitations of PTD-siRNA conjugates, such as aggregation and precipitation.
To enhance mRNA degradation efficiency compared to existing methods like lipofection.

Main Methods:

Development of a PTD-DRBD fusion protein to bind and stabilize siRNA.

More Related Videos

RNAi Interference by dsRNA Injection into Drosophila Embryos

RNAi Interference by dsRNA Injection into Drosophila Embryos

Published on: April 11, 2011

Bacterial Delivery of RNAi Effectors: Transkingdom RNAi

Bacterial Delivery of RNAi Effectors: Transkingdom RNAi

Published on: August 18, 2010

Related Experiment Videos

Last Updated: Jun 7, 2026

Inducible and Reversible Dominant-negative (DN) Protein Inhibition

Inducible and Reversible Dominant-negative (DN) Protein Inhibition

Published on: January 7, 2019

RNAi Interference by dsRNA Injection into Drosophila Embryos

RNAi Interference by dsRNA Injection into Drosophila Embryos

Published on: April 11, 2011

Bacterial Delivery of RNAi Effectors: Transkingdom RNAi

Bacterial Delivery of RNAi Effectors: Transkingdom RNAi

Published on: August 18, 2010

Utilizing three TAT PTDs fused with a double-stranded RNA-binding domain (DRBD).

Evaluating the fusion protein's ability to mask siRNA's negative charge and prevent aggregation.

Main Results:

The PTD-DRBD fusion protein effectively binds siRNA, preventing aggregation and precipitation.
This novel delivery system facilitates non-cytotoxic mRNA degradation within cells.
The PTD-DRBD fusion protein strategy demonstrated superior efficacy compared to traditional lipofection.

Conclusions:

PTD-DRBD fusion protein represents a promising advancement in siRNA delivery technology.
This method offers a safe and highly efficient approach for intracellular delivery of nucleic acids.
The strategy holds potential for improving the therapeutic efficacy of siRNA-based treatments.